Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two-stage randomization designs in drug development.

Marcel Wolbers1, Jeffrey D Helterbrand

  • 1Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland. wolbersm@uhbs.ch

Statistics in Medicine
|June 24, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bayesian analysis of the causal reference-based model for missing data in clinical trials.

Journal of biopharmaceutical statistics·2026
Same author

Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial.

Nature medicine·2026
Same author

Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials.

Statistics in medicine·2025
Same author

Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint.

Statistical methods in medical research·2025
Same author

Estimation Methods for Estimands Using the Treatment Policy Strategy; a Simulation Study Based on the PIONEER 1 Trial.

Pharmaceutical statistics·2025
Same author

Statistical analysis plan for the LAST ACT clinical trial; a Leukotriene A4 hydrolase Stratified non-inferiority Trial of Adjunctive Corticosteroids for HIV-negative adults with Tuberculous meningitis.

Wellcome open research·2025
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

A two-stage randomization design (TSRD) efficiently evaluates new oncology drugs in both induction and maintenance therapy settings. This approach offers advantages over multiple single randomization designs (SRDs) in clinical trial efficiency.

Area of Science:

  • Oncology
  • Clinical Trial Design
  • Biostatistics

Background:

  • Determining optimal use of new oncology agents (induction, maintenance, or both) is a key challenge.
  • Standard of care (SOC) induction therapy followed by maintenance requires careful strategic planning for new drug integration.

Purpose of the Study:

  • To evaluate the efficiency of two-stage randomization designs (TSRDs) for oncology drug development.
  • To compare TSRDs with sequential single randomization designs (SRDs) regarding sample size and decision-making timelines.

Main Methods:

  • Survey of recent statistical methods for analyzing time-to-event endpoints in TSRDs.
  • Simulation study comparing TSRDs with various SRD strategies.
  • Discussion of issues including sample size calculation and multiplicity in TSRDs.

Related Experiment Videos

Main Results:

  • TSRDs allow simultaneous evaluation of induction and maintenance therapy roles for new oncology agents.
  • The study compares the overall sample size and time to clinical decisions between TSRDs and SRD-based strategies.

Conclusions:

  • TSRDs offer a potentially more efficient framework for oncology drug development compared to multiple SRDs.
  • Further investigation into statistical methods and practical considerations for TSRDs is warranted.